Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

SEOM clinical guidelines for the treatment of invasive bladder cancer.

Morales R, Font A, Carles J, Isla D.

Clin Transl Oncol. 2011 Aug;13(8):552-9. doi: 10.1007/s12094-011-0696-8.

PMID:
21821489
2.

[Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma].

Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA; European Association of Urology.

Actas Urol Esp. 2010 Jan;34(1):51-62. Spanish.

PMID:
20223133
3.

The updated EAU guidelines on muscle-invasive and metastatic bladder cancer.

Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA.

Eur Urol. 2009 Apr;55(4):815-25. doi: 10.1016/j.eururo.2009.01.002. Epub 2009 Jan 13. Review.

PMID:
19157687
4.

Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA; European Association of Urology (EAU).

Eur Urol. 2011 Jun;59(6):1009-18. doi: 10.1016/j.eururo.2011.03.023. Epub 2011 Mar 23. Review.

PMID:
21454009
5.

[Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines].

Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA; European Association of Urology.

Actas Urol Esp. 2012 Sep;36(8):449-60. Epub 2012 Mar 2. Spanish.

PMID:
22386114
6.

SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).

Lázaro M, Gallardo E, Doménech M, Pinto Á, Del Alba AG, Puente J, Fernández O, Font A, Lainez N, Vázquez S.

Clin Transl Oncol. 2016 Dec;18(12):1197-1205. Epub 2016 Nov 29.

7.

EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A; European Association of Urology.

Eur Urol. 2014 Apr;65(4):778-92. doi: 10.1016/j.eururo.2013.11.046. Epub 2013 Dec 12.

PMID:
24373477
9.

Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?

Kuczyk M, Turkeri L, Hammerer P, Ravery V; European Society for Oncological Urology.

Eur Urol. 2003 Jul;44(1):57-64. Review.

PMID:
12814676
10.

Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.

Efstathiou JA, Spiegel DY, Shipley WU, Heney NM, Kaufman DS, Niemierko A, Coen JJ, Skowronski RY, Paly JJ, McGovern FJ, Zietman AL.

Eur Urol. 2012 Apr;61(4):705-11. doi: 10.1016/j.eururo.2011.11.010. Epub 2011 Nov 12.

PMID:
22101114
11.

SEOM clinical guidelines for the treatment of non-small-cell lung cancer: an updated edition.

Trigo Pérez JM, Garrido López P, Felip Font E, Isla Casado D; SEOM (Spanish Society for Medical Oncology).

Clin Transl Oncol. 2010 Nov;12(11):735-41.

PMID:
20974565
13.

Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.

Izawa JI, Chin JL, Winquist E.

Can J Urol. 2006 Jun;13 Suppl 3:48-53. Review.

PMID:
16818012
14.

Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.

Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.

J Urol. 2006 Dec;176(6 Pt 1):2414-22; discussion 2422.

PMID:
17085118
15.

Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.

Maarouf AM, Khalil S, Salem EA, ElAdl M, Nawar N, Zaiton F.

BJU Int. 2011 May;107(10):1605-10. doi: 10.1111/j.1464-410X.2010.09564.x. Epub 2010 Sep 3.

16.
17.

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.

Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.

J Urol. 2006 Aug;176(2):493-8; discussion 498-9.

PMID:
16813876
18.

Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.

George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.

Urology. 2004 Sep;64(3):488-93. Review.

PMID:
15351577
19.

Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.

Milowsky MI, Stadler WM, Bajorin DF.

BJU Int. 2008 Nov;102(9 Pt B):1339-44. doi: 10.1111/j.1464-410X.2008.07980.x. Review.

PMID:
19035902
20.

Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

Sternberg CN, Donat SM, Bellmunt J, Millikan RE, Stadler W, De Mulder P, Sherif A, von der Maase H, Tsukamoto T, Soloway MS.

Urology. 2007 Jan;69(1 Suppl):62-79. Review.

PMID:
17280909

Supplemental Content

Support Center